Loading stock data…
Prestige Consumer Healthcare Inc (PBH)
$49.79-2.47 (-4.73%)
Market ClosedLast close Sep 8
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Prestige Consumer Healthcare Inc. in the Healthcare sector is trading at $49.79 with a market capitalization of $2.2B. Wall Street consensus targets $67.80 (5 analysts), implying a +36.2% move over the next 12 months. The stock is currently 30% below its 52-week high of $71.07, remaining 12.3% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +36.2% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $265.71M↓ | $281.62M↓ | $283.44M↑ | $274.11M↑ | $249.53M |
| Gross Profit | $136.19M↓ | $146.30M↓ | $157.37M↑ | $151.58M↑ | $140.33M |
| Operating Income | $52.52M↓ | $75.49M↓ | $82.49M↑ | $79.67M↑ | $71.76M |
| Net Income | $29.18M↓ | $53.93M↑ | $46.70M↑ | $42.21M↓ | $47.47M |
Peer Comparison
JNJUNHPFE
Fundamentals
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.22B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.08%
Volume
Today's trading volume
417,571
Recent News
Is This the Right Time to Add PBH Stock to Your Portfolio?
Prestige Consumer Healthcare gains from acquisitions, e-commerce growth and strong cash flow, though currency swings and high debt remain key risks.
PBH vs. SYK: Which Stock Is the Better Value Option?
PBH vs. SYK: Which Stock Is the Better Value Option?
Prestige Consumer Healthcare (PBH) Bets Big On M&A, But Can Clear Eyes Recover?
Prestige Consumer Healthcare (NYSE:PBH) closed two acquisitions within three weeks this summer, adding roughly $240 million in annualized revenue to a portfolio anchored by Dramamine and Compound W. The first quarter fiscal 2027 earnings call, held August 6, showed a company beating its own targets even before Breathe Right and LaCorium Health joined the mix. […]
Prestige Consumer Healthcare (PBH) Q1 2027 Earnings Call Transcript
Acquisitions drive 6.5% revenue growth and portfolio diversification.
PBH or SYK: Which Is the Better Value Stock Right Now?
PBH vs. SYK: Which Stock Is the Better Value Option?